China Dasheng Biotechnology Co. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
China Dasheng Biotechnology Co. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between China Dasheng Biotechnology Co. and its competitors. This provides our Clients with a clear understanding of China Dasheng Biotechnology Co. position in the Chemicals Industry.
Scope
- The report contains the company’s profile and data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
- The SWOT-analysis provides information about the company’s strengths, weaknesses, opportunities, and possible threats against it.
- The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency.
- It also shows the company’s income statement and ratio trend-charts, with balance sheets and cash flows presented on an annual and quarterly basis.
- Company’s financial ratios are directly compared with those of its competitors through industry averages.
- The report provides relevant news, an analysis of PR-activity, and stock price movements.
- The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms.
The benefits of buying the Report are as follows:
- Readers will gain an unrivalled in-depth knowledge about the company.
- The report will help the management of your business environment. This will be achieved through the report’s unique analysis of both the market and company’s competitors, and by providing detailed information about the internal and external factors that affect the relevant industry.
- Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
- The report will help you to find prospective partners and suppliers.
- The annual profitability data provided in the report will assist and strengthen your company’s decision-making processes.
About China Dasheng Biotechnology Co.
China Dasheng Biotechnology Company engages in the production, marketing, and distribution of bacteria based products, which are used as additives for livestock feed and crop cultivation.
The company has two majority-owned subsidiaries in China. It has 80% interest in Hainan Lushen Biology Technology Co., Ltd. (Lushen), which engages in developing, manufacturing, and marketing artificial microorganisms (AM), high-efficiency microorganism (HM) based biological bacterium blends, and biological preservatives. The company also has a 60% interest in Yangling Elemiss Foods Co., Ltd. (Elemiss), which engages in developing, manufacturing, and marketing artificial microorganism (AM) based biological bacterium blends, and Bulgarian lactobacillus live stock feed additives.
Products
AM/HM bacteria based additives for crops: These bacterial blends, consisting of the companys proprietary and specially cultivated strain solution, Bulgaria lactobacillus, beer microzyme, and dark red spirilla, can improve the beneficial microorganism colonies in soil, while inhibiting the reproduction of harmful fungi and putrefactive bacteria, and are intended to improve nutrient absorption, and reduce crop and livestock diseases.
AM/HM bacteria based additives for livestock feed: These bacterial blends are intended to soften the livestock feed and restrain the growth and reproduction of pathogenic bacteria, while supplying beneficial nutriments, such as organic acid, vitamins, enzyme, antibiotics, mycelium protein, as well as other growth-enhancing substances, thereby balancing the nutrients in the feed.
FGW bacterial based preservatives: These preservatives when applied to animal specimens, the nontoxic, colorless, and side-effect free liquid helps preserve superior quality specimens for scientific research. When sprayed on agricultural produce, it can preserve the freshness under normal atmospheric and temperature conditions.
Bacteria based fertilizer: The companys liquid fertilizer is suited for application on plants, specifically vegetable and fruit leaves. When applied on plants, the company has found that the plants' resistance against freezing and disease increases.
Production Capacity
The companys Lanzhou plant has a designed AM-/HM-based biological bacterial blends output capacity of 2,000 metric tons per year, including 1,400 metric tons for crops and 600 metric tons for live stock feeding. Lushen has a designed AM/HM output capacity of 1,700 metric tons per year. Elemiss has a designed output capacity of 1,200 metric tons per year.
Customers
The company's customers are institutional buyers, including state-owned farms and plantations, fertilizer and feedstock manufacturers; agricultural supplies companies; and agrotech research institutes across China.
Suppliers
The company's major supplier is Dasheng Trading Co., Ltd.
Competition
The companys major competitors in China include Jiangxi Tianyi Bioengineering Development Co., Ltd.; Guangxi Nanguochun Bioengineering Development Co., Ltd.; Shaanxi Bodisen Bioengineering Co., Ltd.; Chengdu Nengsheng Biotech Co., Ltd.; Dalian Sanke Tech (Group) Co., Ltd; Guangxi Beihai Penshibao Co., Ltd; Henan Luo Xiaowang Group; and Shangdong Tianda 2116.
History
China Dasheng Biotechnology Company was founded in 2002.
Contents
RESEARCH METHODOLOGY
DISCLAIMER
1. CHINA DASHENG BIOTECHNOLOGY CO. COMPANY PROFILE
1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History
2. CHINA DASHENG BIOTECHNOLOGY CO. BUSINESS OVERVIEW
2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units
3. CHINA DASHENG BIOTECHNOLOGY CO. SWOT ANALYSIS
3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats
4. CHINA DASHENG BIOTECHNOLOGY CO. FINANCIAL ANALYSIS
4.1. Financial Statements
4.1.1. Income Statement
4.1.2. Balance Sheet
4.1.3. Cash Flow
4.2. Financial Ratios
4.2.1. Profitability
4.2.2. Margin Analysis
4.2.3. Asset Turnover
4.2.4. Credit Ratios
4.2.5. Long-Term Solvency
4.2.6. Growth Over Prior Year
4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot
5. CHINA DASHENG BIOTECHNOLOGY CO. COMPETITORS AND INDUSTRY ANALYSIS
5.1. China Dasheng Biotechnology Co. Direct Competitors
5.2. Comparison of China Dasheng Biotechnology Co. and Direct Competitors Financial Ratios
5.3. Comparison of China Dasheng Biotechnology Co. and Direct Competitors Stock Charts
5.4. China Dasheng Biotechnology Co. Industry Analysis
5.4.1. Chemicals Industry Snapshot
5.4.2. China Dasheng Biotechnology Co. Industry Position Analysis
6. CHINA DASHENG BIOTECHNOLOGY CO. NEWS & EVENTS
6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events
7. CHINA DASHENG BIOTECHNOLOGY CO. EXPERTS REVIEW
7.1. Experts Opinion
7.2. Experts Estimates
APPENDIX 1: RATIO DEFINITIONS
LIST OF TABLES
Table 1. China Dasheng Biotechnology Co. Key Facts
Table 2. China Dasheng Biotechnology Co. Profitability
Table 3. China Dasheng Biotechnology Co. Management Effectiveness
Table 4. China Dasheng Biotechnology Co. Income Statement Key Figures
Table 5. China Dasheng Biotechnology Co. Balance Sheet Key Figures
Table 6. China Dasheng Biotechnology Co. Cash Flow Statement Key Figures
Table 7. Financial Performance Abbreviation Guide
Table 8. China Dasheng Biotechnology Co. Key Executives
Table 9. China Dasheng Biotechnology Co. Key Executives Biographies *
Table 10. China Dasheng Biotechnology Co. Key Executives Compensations *
Table 11. China Dasheng Biotechnology Co. Key Executives Stock Options *
Table 12. China Dasheng Biotechnology Co. Major Shareholders
Table 13. China Dasheng Biotechnology Co. History
Table 14. China Dasheng Biotechnology Co. Products
Table 15. China Dasheng Biotechnology Co. Revenues by Product
Table 16. China Dasheng Biotechnology Co. Revenues by Region
Table 17. China Dasheng Biotechnology Co. Offices and Representations
Table 18. China Dasheng Biotechnology Co. SWOT Analysis
Table 19. China Dasheng Biotechnology Co. Income Statement 2008-2011 Including 4-years Trends
Table 20. China Dasheng Biotechnology Co. Income Statement Latest 4 Quarters Including Trends
Table 21. China Dasheng Biotechnology Co. Balance Sheet 2008-2011 Including Trends
Table 22. China Dasheng Biotechnology Co. Balance Sheet Latest 4 Quarters Including Trends
Table 23. China Dasheng Biotechnology Co. Cash Flow 2008-2011 Including Trends
Table 24. China Dasheng Biotechnology Co. Cash Flow Latest 4 Quarters Including Trends
Table 25. China Dasheng Biotechnology Co. Profitability Ratios
Table 26. China Dasheng Biotechnology Co. Margin Analysis Ratios
Table 27. China Dasheng Biotechnology Co. Asset Turnover Ratios
Table 28. China Dasheng Biotechnology Co. Credit Ratios
Table 29. China Dasheng Biotechnology Co. Long-Term Solvency Ratios
Table 30. China Dasheng Biotechnology Co. Financial Ratios Growth Over Prior Year
Table 31. China Dasheng Biotechnology Co. Capital Market Snapshot
Table 32. China Dasheng Biotechnology Co. Direct Competitors Key Facts
Table 33. China Dasheng Biotechnology Co. Direct Competitors Profitability Ratios
Table 34. China Dasheng Biotechnology Co. Direct Competitors Margin Analysis Ratios
Table 35. China Dasheng Biotechnology Co. Direct Competitors Asset Turnover Ratios
Table 36. China Dasheng Biotechnology Co. Direct Competitors Credit Ratios
Table 37. China Dasheng Biotechnology Co. Direct Competitors Long-Term Solvency Ratios
Table 38. Chemicals Industry Statistics
Table 39. China Dasheng Biotechnology Co. Industry Position
Table 40. China Dasheng Biotechnology Co. vs. Industry Income Statement Analysis
Table 41. China Dasheng Biotechnology Co. vs. Industry Balance Sheet Analysis
Table 42. China Dasheng Biotechnology Co. vs. Industry Cash Flow Analysis
Table 43. China Dasheng Biotechnology Co. vs. Industry Ratios Comparison
Table 44. China Dasheng Biotechnology Co. Consensus Recommendations*
Table 45. China Dasheng Biotechnology Co. Analyst Recommendation Summary*
Table 46. China Dasheng Biotechnology Co. Price Target Summary*
Table 47. China Dasheng Biotechnology Co. Experts Recommendation Trends*
Table 48. China Dasheng Biotechnology Co. Revenue Estimates Analysis*
Table 49. China Dasheng Biotechnology Co. Earnings Estimates Analysis*
Table 50. China Dasheng Biotechnology Co. Historical Surprises*
Table 51. China Dasheng Biotechnology Co. Revenue Estimates Trend*
Table 52. China Dasheng Biotechnology Co. Earnings Estimates Trend*
Table 53. China Dasheng Biotechnology Co. Revenue Revisions*
Table 54. China Dasheng Biotechnology Co. Earnings Revisions*
LIST OF FIGURES
Figure 1. China Dasheng Biotechnology Co. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Figure 2. China Dasheng Biotechnology Co. Profit Margin Chart
Figure 3. China Dasheng Biotechnology Co. Operating Margin Chart
Figure 4. China Dasheng Biotechnology Co. Return on Equity (ROE) Chart
Figure 5. China Dasheng Biotechnology Co. Return on Assets (ROA) Chart
Figure 6. China Dasheng Biotechnology Co. Debt to Equity Chart
Figure 7. China Dasheng Biotechnology Co. Current Ratio Chart
Figure 8. China Dasheng Biotechnology Co. 1-year Stock Charts
Figure 9. China Dasheng Biotechnology Co. 5-year Stock Charts
Figure 10. China Dasheng Biotechnology Co. vs. Main Indexes 1-year Stock Chart
Figure 11. China Dasheng Biotechnology Co. vs. Direct Competitors 1-year Stock Charts
Figure 12. China Dasheng Biotechnology Co. Article Density Chart
* – Data availability depends on company’s security policy.
The complete financial data is available for public traded companies.
The above Company Fundamental Report is a half-ready report.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get up-to-date version for the same price.